In a randomized, double-blind, prospective trial we compared the efficacy of pre-treatment with nitrous oxide (with or without premixed lignocaine in propofol) for the prevention of propofol-induced pain. Ninety consecutive patients were recruited in the study and divided into three groups of 30 each, who received either 50% nitrous oxide in oxygen along with lignocaine 40 mg mixed in 1% propofol 20 ml (Group NL), 50% nitrous oxide in oxygen without lignocaine in propofol (Group N), and 50% oxygen in air with lignocaine mixed in propofol 40 mg (Group L). Pain scores were graded on a four point verbal rating scale (0-3). Eighty-nine patients completed the study while one patient developed excitement, agitation and tremor during nitrous oxide in oxygen inhalation. Eleven patients (36.7%) complained of pain in the group L compared to 7 (23.3%), and 1 (3.3%), in groups N and NL respectively [group NL vs group L (P<0.001) and group NL vs N (P<0.001)]. There was no statistical difference observed between group N and group L. Inhalation of 50% nitrous oxide reduces pain on propofol injection. The combination of 50% nitrous oxide and lignocaine mixed with propofol was the most effective treatment.
Pain during induction of anaesthesia is distressing and increases anxiety and stress among patients just before surgery. The incidence of pain on propofol injection is anywhere between 40-86% 1 . Various factors appear to affect its incidence (e.g. concentration in the aqueous phase, site of injection, size of vein, speed of injection, temperature of propofol and concomitant use of other drugs) 2 .
Different methods have been used to reduce the incidence or intensity of this adverse effect with varying success [2] [3] [4] . Nitrous oxide (N 2 O) is an analgesic gas that been used for more than 100 years. We evaluated the efficacy of N 2 O in reducing pain on propofol injection in a prospective, randomized, double-blinded, controlled clinical trial.
METHODS
After approval by our hospital ethics committee, we obtained informed consent from all patients.
Based on an estimated incidence of 80% of patients experiencing pain on propofol injection, the sample size required to detect a 50% reduction in incidence of pain at 5% significance and a power of 90% was 30 patients per group. Hence, we studied 90 patients (ASA physical status 1 or 2, aged 16-55 y) of both sexes undergoing elective surgery (viz. abdominal surgery, spine surgery, resection of anterior mediastinal mass and lung surgery) under general anaesthesia. Exclusion criteria included patients taking regular sedatives or analgesics, allergy to lignocaine, a history of movement disorder or drug abuse, inability to cooperate or give informed consent, anticipated difficult airway, thrombophlebitis or any other painful lesion, or contraindication to N 2 O (e.g. pneumothorax). We also considered the presence of chronic obstructive pulmonary disease (COPD) and respiratory infection to be a contraindication to N 2 O use.
Patients were randomly allocated to receive one of the three treatments by drawing of lots (i.e. drawing blindly from the box that exactly contained 90 coded lots; 30 in each group). Patients (30 in each group) received either inhalation of 50% N 2 O in O 2 for 3 minutes along with lignocaine 2% 2 ml (40 mg) mixed in propofol 1% 20 ml (Group NL), inhalation of 50% N 2 O in O 2 for 3 minutes along with propofol 1% with 2 ml normal saline (Group N), or inhalation of 50% O 2 in air along with lignocaine 2% 2 ml (40 mg) mixed in propofol 1% 20 ml (Group L) (control). The lignocaine-propofol mixture or propofol-normal saline was freshly prepared to make same total volume (22 ml) in all the groups. The syringes were prepared by an anaesthetist who was not involved in the study or in data collection, in such a way that the anaesthetist (PKS) who was involved in data collection did not know their contents. Decoding was performed after completion of the study in all patients.
All patients received glycopyrrolate 0.2 mg IM as premedication one hour before induction of anaesthesia. Patients were monitored during induction of anaesthesia with ECG, pulse oximetry and non-invasive blood pressure. A 20-gauge cannula was inserted for administration of propofol into the dorsum of one of the hand veins without the use of local anaesthetic and subsequently an intravenous Ringer's lactate infusion was started. A separate 18-gauge cannula was inserted into another arm vein with the use of skin infiltration with local anaesthetic for administration of other medications. No further injections were made into the study vein after propofol was administered; however, the IV infusion was continued until completion of surgical procedures.
Fifty per cent N 2 O in O 2 or O 2 in air mixture was delivered to the patients via an anaesthesia machine (Aestiva/5, Datex-Ohmeda, Helsinki, Finland). Before any IV or inhalation agent was administered, patients were reminded about the study. However, they were blinded about the group to which they had been assigned. Patients were asked to breathe the study gas via a facemask for 3 minutes prior to induction. During this time a screen was placed in front of the flowmeters in such a fashion that the first author (PKS), who collected the data, and second author (PKN) who was assisting in holding the mask were blinded to the group assigned. Once the patient had inhaled 50% N 2 O:O 2 or the O 2 :air mixture for 3 minutes, propofol 1% with or without lignocaine was injected using a three-way stopcock connected directly to the cannula. The IV infusion was stopped while injecting the drug. The rate of injection was 2.5 ml every 5 s and continued until loss of consciousness was reached as assessed by standard clinical criteria (no verbal response, loss of eyelash reflexes). Every 5-10 s during the propofol injection, the pain score was obtained by asking the patient a standard question about the comfort of the injection and scoring the verbal response and behavioural signs according to a four point verbal rating scale (VRS) [0, no pain; 1, mild pain (or grimace); 2, moderate pain (or grimace and cry); 3, severe pain (or cry and with-drawal of arm)] 5 . Any score other than 0 was taken to represent pain on injection. Any adverse effects were also noted. Further anaesthesia continued using drugs and techniques at the discretion of the attending anaesthetist.
Statistical analysis was performed by using SPSS 10.0 (SPSS, Chicago, IL). Demographic data and the total dose of propofol used were analysed by analysis of variance (ANOVA) tests. The incidence of pain was analysed by Chi square test and by comparing two proportions by normal approximation ("Z" test). For analysis of severity of pain, "Z" test for proportion was used. P value <0.05 was considered statistically significant.
RESULTS
Out of 90 patients, 89 completed the study, while one patient in Group N developed excitement, agitation and tremor during 50% N 2 O in O 2 inhalation and could not complete the study. As the complication occurred after randomization, he was included in the study for data analysis on the basis of an intention to treat model. This patient was "presumed" to have grade 3 pain on VRS (severe pain) and hence pain data was included accordingly for statistical analysis. Out of 90 patients, 50 were male and 40 were female.
There were no significant differences in the demographic characteristics or amount of propofol administered between the groups (Table 1) . Pain characteristics are shown in Table 2 .
The three groups were statistically different ( χ 2 = 10.14; P=0.006). The incidence of pain in Group NL (3.3%) was significantly reduced compared with Group N (23.3%) (P<0.001) or Group L (36.7%) (P<0.001). There were more number of patients in group L who experienced pain than in Group N, however, the difference was statistically not significant.
With regard to severity of pain, there were no statistical difference between the groups in different grading of pain scores, except for the percentage of the patients who experienced grade 1 pain in group NL (3.3%) compared with group L (26.7%) (P<0.05).
DISCUSSION
Our study demonstrated that prior N 2 O inhalation reduces the incidence of pain on propofol injection and provides an analgesic effect. The combination of N 2 O inhalation and lignocaine mixed with propofol was significantly more effective than treatment with either technique alone.
Propofol causes pain on injection in 40-86% of patients, particularly when it is administered through small veins on the back of the hands 1,6 . Although the exact aetiology of pain remains obscure, numerous techniques have been used to reduce its incidence and intensity 2, 4 . The most popular methods involve the use of lignocaine by pre-treatment or by mixing lignocaine with propofol 3,6-7 . However, even using lignocaine, the incidence of pain has been reported to be anywhere between 32 and 48% 7 . In our patients who received lignocaine only, the incidence of pain was 36.7%, which is similar to the findings of other studies.
Pain during induction of anaesthesia may cause agitation, hinder the smooth induction of anaesthesia, increase anxiety, and may even cause adverse effects on the cardiovascular system in patients who are at risk 8 . Thus, an effective method of prevention would be beneficial as well as desirable. N 2 O has been used for many years to provide analgesia for various day care procedures 9 . Beh et al 10 recently reported the use of N 2 O in reducing pain on propofol injection in children. The authors compared the effects of 50% N 2 O in O 2 along with lignocaine mixed in propofol with that of 100% O 2 along with lignocaine mixed in propofol in children for alleviating pain on propofol administration. As in our study, they also did not use any sedative premedication in their patients; however, they used EMLA cream for venous cannulation. They found a significant decrease in incidence of pain from 36% to 4% with the use of N 2 O along with propofol mixed with lignocaine; however, none of their children reported severe pain. Further, they did not study the effect of N 2 O alone without the use of lignocaine in propofol on propofol injection pain. We found the incidence of pain to be 3.3% with the use of N 2 O along with propofol mixed with lignocaine. However, the incidence of pain was higher (23.4%) in patients who received N 2 O without lignocaine than N 2 O with lignocaine group (P<0.001).
The severity of pain also appeared to be significantly lower in group NL compared with group L. However, as we did not have sufficient power to study severity of pain, a firm conclusion cannot be drawn between the groups in this regard. A further large study would be needed to resolve the issue.
We used 50% N 2 O in our study, as we believe that this concentration would be appropriate for alleviating pain on propofol injection without causing too much sedation, thus making pain evaluation easy and without compromising safety in terms of side-effects. Further, this concentration has been used in the past to evaluate the analgesic effects of N 2 O in other clinical settings [9] [10] [11] . Moreover, 50% N 2 O in O 2 is commonly offered as an analgesic to women in labour.
Only one patient in the N 2 O group (Group N) developed side effects; i.e. excitement, agitation and tremor. In the first stage of anaesthesia patients may show signs of excitement or agitation. Since the effect of N 2 O wears off within minutes of decreasing the concentration of inhaled gas, these effects can be quickly reversed by stopping the N 2 O, and hence these complications may be considered short-lived. Nevertheless, the possibility of this complication occurring with the use of N 2 O must be considered.
Lignocaine added to propofol has previously been shown to reduce pain and is the most commonly used agent in the prevention of pain due to propofol 6, 7 . Therefore, we chose lignocaine as a positive control group and used lignocaine 40 mg in propofol 1% 20 ml, because it is more effective than lignocaine 10 mg or 20 mg in 20 ml 1% propofol 12, 13 . Further, we controlled other potential confounding variables as well as double-blinding the study.
We did not use premedication for two reasons. First, use of premedication has been found to influence the incidence of injection pain 14 ; secondly, as N 2 O can have a synergistic sedative effect with other sedative drugs 15 , it may make the assessment of pain more difficult. We excluded patients with a known contraindication to N 2 O. We also excluded patients known to have anticipated difficult airway, as the administration of 50% N 2 O in O 2 would be less safe than 100% O 2 . It is advisable to use other methods to alleviate pain of propofol injection in these conditions.
The visual analogue scale (VAS) and VRS 5 are commonly used to measure pain in clinical settings. Although, the VAS is the most sensitive for pain detection and evaluation of analgesic efficacy 16 , we used four point VRS in our study because it is simple to apply and readily understood by patients. Most of the studies on pain on propofol injection have used this system, thus allowing easier comparison with literature. There is little evidence that a VAS would enhance the numerical interpretation of a single subjective report of transient pain. Moreover, VAS may not be an appropriate measuring instrument during a rapidly changing state of consciousness such as anaesthesia induction.
In conclusion, pre-treatment (inhalation) with N 2 O reduces pain on propofol injection. Prior inhalation of N 2 O along with lignocaine mixed with propofol was the most effective treatment for reducing propofol-induced pain. N 2 O may be a useful alternative to other drugs in preventing pain of propofol injection.
